Tech Company Financing Transactions

Ilypsa Funding Round

5AM Ventures, Delphi Ventures and Johnson & Johnson Development Corporation participated in a $16 million venture round for Ilypsa. The round was announced on 3/31/2006.

Transaction Overview

Company Name
Ilypsa
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Undisclosed
Investors

5AM Ventures

Delphi Ventures (Deepa Pakianathan)

Johnson & Johnson Development Corporation (Brad Vale)

Sprout Group (Vijay Lathi)

U.S. Venture Partners (Casper DeClercq)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3406 Central Expressway
Santa Clara, CA 95051
USA
Phone
(408) 215-2800
Website
www.ilypsa.com
Email Address
Not Recorded
Overview
Ilypsa, Inc. is a biopharmaceutical company focused on developing a proprietary pipeline of novel non-absorbed polymeric drugs for important therapeutic applications.
Profile
Ilypsa LinkedIn Company Profile
Social Media
Ilypsa Company Twitter Account
Company News
Ilypsa News
Facebook
Ilypsa on Facebook
YouTube
Ilypsa on YouTube

Management Team

Title
Name
Email & Social
Chairman
Scott Rocklage
  Scott Rocklage LinkedIn Profile  Scott Rocklage Twitter Account  Scott Rocklage News  Scott Rocklage on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/31/2006: Tabula Digita venture capital transaction
Next: 3/31/2006: Primarion venture capital transaction

 

Share this article

 

About Database of VC Transactions

We record funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.